8:00 - 8:30 am
Registration Desk Open & Continental Breakfast
8:30 am - 8:50 am
Welcome & SCI Update
Steven Artandi, MD, PhD
Director, Stanford Cancer Institute
Lloyd Minor, MD (Recorded message)
Dean, School of Medicine, Stanford University
8:50 - 9:35 am
Session 1: Clinical and Translational Advances
James Ford, MD [Chair]
Professor, Medicine and Genetics
Kara Davis, DO
Associate Professor, Pediatrics - Hematology & Oncology
Uridine as a Targetable Metabolic Dependency in Acute Lymphoblastic Leukemia
Melinda Telli, MD
Director, Clinical Research, Stanford Cancer Institute
Leveraging ctDNA-MRD in Early Breast Cancer
Jason Gotlib, MD, MS
Professor, Medicine (Hematology)
Pemigatinib for Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
9:45 - 9:55 am
Break
9:55 - 10:40 am
Session 2: Population Sciences
John Witte, PhD, MS [Chair]
Professor, Epidemiology and Population Health, Biomedical Data Science and Genetics
Allison Kurian, MD, MSc
Professor of Medicine and Epidemiology and Population Health
Leveraging Population-Based Data for High-Impact Clinical Research
Marvin Langston, PhD
Assistant Professor, Epidemiology and Population Health
Adiposity, Hypertension, and Renal Cell Cancer: Towards a Cardiometabolic Framework for Prevention and Survivorship
David Rehkopf, PhD, MPH
Associate Professor, Epidemiology and Population Health
Real-World Data Resources at the Stanford Center for Population Health Sciences
10:40 - 11:25 am
Lightning Talks
11:30 - 12:30 pm
Poster Judging and Lunch Break
12:30 - 1:15 pm
Concurrent Breakout Session
1) Stanford Cancer Institute Data Dashboard Demonstration (Main Room)
Alyce Adams, PhD
Associate Director, Cancer Health Equity and Community Engagement, Stanford Cancer Institute
Dinah Trevil, MPA
Executive Director, Office of Cancer Health Equity and Community Engagement, Stanford Cancer Institute
2) Deep Data Needs and Challenges in Precision Health (Room LKSC 208)
Amir Bahmani, PhD, MS
Director, Stanford's Deep Data Research Center
1:15 - 1:25 pm
Break
1:25 - 2:10 pm
Session 3: Cancer Biology
Roeland Nusse, PhD [Chair]
Professor, Development Biology
Paul Mischel, MD
Professor and Vice Chair for Research, Department of Pathology
Extrachromosomal DNA (ecDNA): Cancer’s Dynamic Circular Genome
Sydney Lu, MD, PhD
Assistant Professor, Medicine (Hematology)
Identifying and Targeting Transcript Alterations Mediated by Oncogenic SF3B1 Mutations
Julien Sage, PhD
Professor, Pediatrics - Hematology & Oncology and Genetics
Functional Interactions Between SCLC Cells and Immune Cells
2:10 - 2:20 pm
Break
2:20 - 3:05 pm
Session 4: New Therapeutic Modalities
Rajat Rohatgi, MD, PhD [Chair]
Associate Director, Basic Science, Stanford Cancer Institute
Katherine Ferrara, PhD
Professor, Radiology and Division Chief for the Molecular Imaging Program
Radiotheragnostic Design and Deployment at Stanford
Gerald Crabtree, MD
Professor, Pathology and Developmental Biology
Rewiring Cancer Drivers to Activate Cell Death
Steven Banik, PhD
Associate Professor, Chemistry
Detecting and Rewiring Cellular Interactomes
3:05 - 3:15 pm
Break
3:15 - 4:15 pm
Session 5: Cancer Immunotherapy
Edgar Engleman, MD [Chair & Speaker]
Professor, Pathology and Medicine
Deciphering the Tumor Immune Landscape
Lingyin Li, PhD
Professor, Biochemistry
Innate Immune Checkpoint Blockade With an ENPP1 Inhibitor
Ansuman Satpathy, MD, PhD
Associate Professor, Pathology
Designer Genes and Cell States for Cancer Immunotherapy
Allison Betof Warner, MD, PhD
Director, Stanford Advanced Melanoma Program
Ushering in the Era of Solid Tumor Cell Therapy
4:15 pm
Closing Remarks
Steven Artandi, MD, PhD
Director, Stanford Cancer Institute
4:15 - 5:15 pm
Poster Session & Reception